JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kojro, E.
Right arrow Articles by Fahrenholz, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kojro, E.
Right arrow Articles by Fahrenholz, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 12, Issue of March 24, 1995 pp. 6476-6481
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Ligand-induced Cleavage of the V Vasopressin Receptor by a Plasma Membrane Metalloproteinase (*)

(Received for publication, May 18, 1994; and in revised form, January 16, 1995)

Elzbieta Kojro Falk Fahrenholz (§)

From the Max-Planck-Institute of Biophysics, Kennedyallee 70, 60596 Frankfurt am Main, Federal Republic of Germany


ABSTRACT

The proteolytic cleavage of a G protein-coupled peptide hormone receptor, the renal V(2) vasopressin receptor, by a plasma membrane proteinase was investigated. In the absence of protease inhibitors during incubation of bovine kidney membranes with a photoreactive vasopressin agonist, V(2) receptor truncation leads to a labeled receptor fragment with M(r) 30,000. The V(2) receptor-degrading enzyme could be completely inhibited by zinc ions yielding the native V(2) receptor glycoprotein with M(r) 58,000. Studies with inhibitors of metalloendopeptidases involved in peptide hormone metabolism and with peptide substrates spanning the V(2) receptor cleavage site classify the receptor protease as metalloendoproteinase with specificity for longer substrates. Comparison of the NH(2)-terminal protein sequence of the truncated M(r) 30,000 V(2) receptor with the sequence deduced from the cDNA of the cloned bovine V(2) receptor shows that cleavage occurs between Gln and Val of the second transmembrane helix close to an extracellular agonist binding site. V(2) receptor proteolysis was dependent on the presence of a hormonal ligand. It occurred rapidly after hormone binding and led to a loss of ligand binding properties of the truncated V(2) receptor. The data suggest that the endogenous V(2) receptor-degrading metalloendoproteinase regulates V(2) receptor function. The novel pathway may contribute to the termination of signal transmission.


FOOTNOTES

*
This work was supported by Grant SFB 169 from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Max-PlanckInstitute of Biophysics, Kennedyallee 70, 60596 Frankfurt am Main, Germany. Tel.: 69-6303-267; Fax: 69-6303-244.

(^1)
The abbreviations used are: HPLC, high performance liquid chromatography; AEBSF, 4-(2-Aminoethyl)-benzenesulfonyl fluoride hydrochloride; AVP, [8-arginine] vasopressin; DDAVP, 1- deamino [8-D-arginine] vasopressin; FAB, fast atom bombardment; PAGE, polyacrylamide gel electrophoresis; Hepps, 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid.

(^2)
Ufer, E., Postina, R., Gorbulev, V., and Fahrenholz, F.(1995) FEBS Lett, in press.

(^3)
E. Kojro, E. Ufer, and F. Fahrenholz, unpublished observation.


ACKNOWLEDGEMENTS x

We thank Gaby Horter for invaluable technical assistance, Dr. Wolfram Schaefer, Max-Planck-Institute of Biochemistry, Martinsried for mass spectroscopy, Dr. Gerald Gimpl for critically reading, and Solveigh McCormack and Michael Schwalm for typing the manuscript.


©1995 by The American Society for Biochemistry and Molecular Biology, Inc.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Wei, K. Hackmann, H. Xu, G. Germino, and F. Qian
Characterization of cis-Autoproteolysis of Polycystin-1, the Product of Human Polycystic Kidney Disease 1 Gene
J. Biol. Chem., July 27, 2007; 282(30): 21729 - 21737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Fairfax, J. A. Pitcher, M. G. H. Scott, A. R. Calver, M. N. Pangalos, S. J. Moss, and A. Couve
Phosphorylation and Chronic Agonist Treatment Atypically Modulate GABAB Receptor Cell Surface Stability
J. Biol. Chem., March 26, 2004; 279(13): 12565 - 12573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Dupre, Z. Chen, C. Le Gouill, C. Theriault, J.-L. Parent, M. Rola-Pleszczynski, and J. Stankova
Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor
J. Biol. Chem., November 28, 2003; 278(48): 48228 - 48235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Grantcharova, J. Furkert, H. P. Reusch, H.-W. Krell, G. Papsdorf, M. Beyermann, R. Schulein, W. Rosenthal, and A. Oksche
The Extracellular N Terminus of the Endothelin B (ETB) Receptor Is Cleaved by a Metalloprotease in an Agonist-dependent Process
J. Biol. Chem., November 8, 2002; 277(46): 43933 - 43941.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Zhang, J. Li, J.-G. Li, and L.-Y. Liu-Chen
(-)U50,488H [(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] Induces Internalization and Down-Regulation of the Human, but not the Rat, kappa -Opioid Receptor: Structural Basis for the Differential Regulation
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1184 - 1192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Thibonnier, C. L. Plesnicher, K. Berrada, and L. Berti-Mattera
Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E81 - E92.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Jockers, S. Angers, A. Da Silva, P. Benaroch, A. D. Strosberg, M. Bouvier, and S. Marullo
beta 2-Adrenergic Receptor Down-regulation. EVIDENCE FOR A PATHWAY THAT DOES NOT REQUIRE ENDOCYTOSIS
J. Biol. Chem., October 8, 1999; 274(41): 28900 - 28908.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Phalipou, R. Seyer, N. Cotte, C. Breton, C. Barberis, M. Hibert, and B. Mouillac
Docking of Linear Peptide Antagonists into the Human V1a Vasopressin Receptor. IDENTIFICATION OF BINDING DOMAINS BY PHOTOAFFINITY LABELING
J. Biol. Chem., August 13, 1999; 274(33): 23316 - 23327.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Piedagnel, G. Murphy, P. M. Ronco, and B. Lelongt
Matrix Metalloproteinase 2 (MMP2) and MMP9 Are Produced by Kidney Collecting Duct Principal Cells but Are Differentially Regulated by SV40 Large-T, Arginine Vasopressin, and Epidermal Growth Factor
J. Biol. Chem., January 15, 1999; 274(3): 1614 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies
Endocr. Rev., December 1, 1998; 19(6): 673 - 716.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Phalipou, N. Cotte, E. Carnazzi, R. Seyer, E. Mahe, S. Jard, C. Barberis, and B. Mouillac
Mapping Peptide-binding Domains of the Human V1a Vasopressin Receptor with a Photoactivatable Linear Peptide Antagonist
J. Biol. Chem., October 17, 1997; 272(42): 26536 - 26544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Postina, E. Kojro, and F. Fahrenholz
Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor
J. Biol. Chem., December 6, 1996; 271(49): 31593 - 31601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Takino, H. Sato, A. Shinagawa, and M. Seiki
Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library
J. Biol. Chem., September 29, 1995; 270(39): 23013 - 23020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-L. Matharu, S. J. Mundell, J. L. Benovic, and E. Kelly
Rapid Agonist-induced Desensitization and Internalization of the A2B Adenosine Receptor Is Mediated by a Serine Residue Close to the COOH Terminus
J. Biol. Chem., August 3, 2001; 276(32): 30199 - 30207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Gage, K.-A. Kim, T. T. Cao, and M. von Zastrow
A Transplantable Sorting Signal That Is Sufficient to Mediate Rapid Recycling of G Protein-coupled Receptors
J. Biol. Chem., November 21, 2001; 276(48): 44712 - 44720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.